Panel Hep Exchanges track
Lifestyle and Therapeutic Interventions for Metabolic Dysfunction–Associated Steatotic Liver Disease: An Overview and Update Spanning Pediatric and Adult Populations
Sat, Nov 7, 2026 · 1:00–2:00 PM MST Convention Center: Summit 3, The Park @TLM, Hall D, Colorado Convention Center
About this session
Topic experts provide a review and discussion of lifestyle and therapeutic interventions for adult and pediatric patients with metabolic dysfunction–associated steatotic liver disease (MASLD) to avoid hepatic fibrosis progression. Presenters discuss the effectiveness of these interventions in isolation and in combination. <h2 class="objectives__heading d-flex flex-column font-barlow fs-xxxl fw-bold font-style-italic text-uppercase lh-headings text-dark-green"
